Ikarian Capital’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-619,258
Closed -$1.21M 196
2025
Q2
$1.21M Hold
619,258
0.4% 78
2025
Q1
$1.09M Buy
619,258
+535,851
+642% +$1.22M 0.36% 95
2024
Q4
$222K Buy
83,407
+125
+0.2% +$322 0.06% 149
2024
Q3
$191K Sell
83,282
-275,000
-77% -$839K 0.06% 138
2024
Q2
$1.05M Sell
358,282
-275,000
-43% -$839K 0.33% 75
2024
Q1
$2.31M Sell
633,282
-589,570
-48% -$1.13M 0.63% 82
2023
Q4
$1.85M Hold
1,222,852
0.51% 87
2023
Q3
$1.64M Buy
+1,222,852
New +$2.04M 0.61% 82
2022
Q2
Sell
-213,310
Closed -$1.12M 192
2022
Q1
$1.12M Buy
213,310
+13,310
+7% +$74.8K 0.34% 94
2021
Q4
$1.7M Buy
+200,000
New +$1.84M 0.49% 73
2021
Q2
Sell
-250,000
Closed -$2.61M 292
2021
Q1
$2.61M Buy
250,000
+48,192
+24% +$539K 0.39% 183
2020
Q4
$2.36M Buy
+201,808
New +$2.1M 0.43% 144

Other funds holding NUVB